Angiotensin receptor blockers could be superior to angiotensin-converting enzyme inhibitors in COVID-19 management: the potential role of bradykinin
Irish Journal of Medical Science (1971 -) · 2024
DOI: 10.1007/s11845-024-03679-5 ↗Kurz gefasst
Leserbrief in der Zeitschrift Irish Journal of Medical Science (1971 -), 2024. Verfasst von Mina T Kelleni. Beteiligte Einrichtung: Pharmacology Department, College of Medicine, Minia University, Minya, Egypt. drthabetpharm@yahoo.com. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme Inhibitors, Bradykinin, Angiotensin Receptor Antagonists, COVID-19. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pharmacology Department, College of Medicine, Minia University, Minya, Egypt. drthabetpharm@yahoo.com.
- Research Fellow INTI International University, Putra Nilai, Negeri Sembilan, Malaysia. drthabetpharm@yahoo.com.
Zitieren
APA
Kelleni, M. T. (2024). Angiotensin receptor blockers could be superior to angiotensin-converting enzyme inhibitors in COVID-19 management: the potential role of bradykinin. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-024-03679-5
Vancouver
Kelleni MT. Angiotensin receptor blockers could be superior to angiotensin-converting enzyme inhibitors in COVID-19 management: the potential role of bradykinin. Irish Journal of Medical Science (1971 -). 2024. doi:10.1007/s11845-024-03679-5
BibTeX
@article{Kelleni2024,
author = {Kelleni, Mina T},
title = {Angiotensin receptor blockers could be superior to angiotensin-converting enzyme inhibitors in COVID-19 management: the potential role of bradykinin},
journal = {Irish Journal of Medical Science (1971 -)},
year = {2024},
doi = {10.1007/s11845-024-03679-5}
}
EUVIMED